Literature DB >> 26522656

Corticosteroid-binding globulin cleavage is paradoxically reduced in alpha-1 antitrypsin deficiency: Implications for cortisol homeostasis.

Marni A Nenke1, Mark Holmes2, Wayne Rankin3, John G Lewis4, David J Torpy5.   

Abstract

High-affinity corticosteroid-binding globulin (haCBG) is cleaved by neutrophil elastase (NE) resulting in permanent transition to the low cortisol-binding affinity form (laCBG), thereby increasing cortisol availability at inflammatory sites. Alpha-1 antitrypsin (AAT) is the major inhibitor of NE. AAT deficiency (AATD) predisposes patients to early-onset emphysema due to increased proteolytic destruction from the inherent proteinase-antiproteinase imbalance. We hypothesized that AATD may result in increased CBG cleavage in vivo. We collected demographic data and blood samples from 10 patients with AATD and 28 healthy controls measuring total CBG and haCBG levels by parallel in-house ELISAs, as well as AAT, total and free cortisol levels. haCBG was higher (median [range]); 329 [210-551] vs. 250 [175-365] nmol/L; P<0.005, and laCBG lower; 174 [68-229] vs. 220 [119-348] nmol/L; P=0.016 in the AATD group, compared with controls. The ratio of haCBG:total CBG was also higher in AATD; 72 [53-83] vs. 54 [41-72] %; P=0.0001). There was a negative correlation between haCBG:total CBG and AAT levels (P<0.05, R=-0.64). Paradoxically, proteolytic cleavage of CBG was reduced in AATD, despite the recognized increase in NE activity. This implies that NE activity is not the mechanism for systemic CBG cleavage in basal, low inflammatory conditions. Relatively low levels of laCBG may have implications for cortisol action in AATD.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-1 antitrypsin deficiency; Corticosteroid-binding globulin; Cortisol; High-affinity CBG; Low-affinity CBG; Neutrophil elastase

Mesh:

Substances:

Year:  2015        PMID: 26522656     DOI: 10.1016/j.cca.2015.10.028

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Pyrexia and acidosis act independently of neutrophil elastase reactive center loop cleavage to effect cortisol release from corticosteroid-binding globulin.

Authors:  Emily J Meyer; David J Torpy; Anastasia Chernykh; Morten Thaysen-Andersen; Marni A Nenke; John G Lewis; Harinda Rajapaksha; Wayne Rankin; Steven W Polyak
Journal:  Protein Sci       Date:  2020-11-04       Impact factor: 6.725

2.  Asn347 Glycosylation of Corticosteroid-binding Globulin Fine-tunes the Host Immune Response by Modulating Proteolysis by Pseudomonas aeruginosa and Neutrophil Elastase.

Authors:  Zeynep Sumer-Bayraktar; Oliver C Grant; Vignesh Venkatakrishnan; Robert J Woods; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

3.  Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy.

Authors:  Marni A Nenke; Anna Zeng; Emily J Meyer; John G Lewis; Wayne Rankin; Julie Johnston; Svjetlana Kireta; Shilpanjali Jesudason; David J Torpy
Journal:  J Endocr Soc       Date:  2017-02-13

4.  Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients.

Authors:  Anastasia Tchoukaev; Jessica Taytard; Nathalie Rousselet; Carine Rebeyrol; Dominique Debray; Sabine Blouquit-Laye; Marie-Pierre Moisan; Aline Foury; Loic Guillot; Harriet Corvol; Olivier Tabary; Philippe Le Rouzic
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

5.  N-Glycosylation influences human corticosteroid-binding globulin measurements.

Authors:  Lesley A Hill; Zeynep Sumer-Bayraktar; John G Lewis; Eva Morava; Morten Thaysen-Andersen; Geoffrey L Hammond
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

6.  Neutrophil elastase-cleaved corticosteroid-binding globulin is absent in human plasma.

Authors:  Lesley A Hill; Dimitra A Vassiliadi; Ioanna Dimopoulou; Anna J Anderson; Luke D Boyle; Alixe H M Kilgour; Roland H Stimson; Yoan Machado; Christopher M Overall; Brian R Walker; John G Lewis; Geoffrey L Hammond
Journal:  J Endocrinol       Date:  2019-01-01       Impact factor: 4.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.